Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase 1/2 Open Label, Multicenter Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors
NCT Number:
NCT04393298
Phase:
I/II
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Colon, Other Digestive Organ
Study Objectives:
The purpose of the study is to characterize the safety and pharmacokinetic (PK) profile of UCB6114.
Study Documents
(MUSC NetID required for document access)